Literature DB >> 27745555

Multidrug-Resistant Organisms Detected More Than 48 Hours After Hospital Admission Are Not Necessarily Hospital-Acquired.

Stefan Erb1, Reno Frei2, Marc Dangel1, Andreas F Widmer1.   

Abstract

BACKGROUND Infections and colonization with multidrug-resistant organisms (MDROs) identified >48 hours after hospital admission are considered healthcare-acquired according to the definition of the Centers for Disease Control and Prevention (CDC). Some may originate from delayed diagnosis rather than true acquisition in the hospital, potentially diluting the impact of infection control programs. In addition, such infections are not necessarily reimbursed in a healthcare system based on the diagnosis-related groups (DRGs). OBJECTIVE The goal of the study was to estimate the preventable proportion of healthcare-acquired infections in a tertiary care hospital in Switzerland by analyzing patients colonized or infected with MDROs. METHODS All hospitalized patients with healthcare-acquired MDRO infection or colonization (HAMIC) or according to the CDC definition (CDC-HAMIC) were prospectively assessed from 2002 to 2011 to determine whether there was evidence for nosocomial transmission. We utilized an additional work-up with epidemiological, microbiological, and molecular typing data to determine the true preventable proportion of HAMICs. RESULTS Overall, 1,190 cases with infection or colonization with MDROs were analyzed; 274 (23.0%) were classified as CDC-HAMICs. Only 51.8% of CDC-HAMICs had confirmed evidence of hospital-acquisition and were considered preventable. Specifically, 57% of MRSA infections, 83.3% of VRE infections, 43.9% of ESBL infections, and 74.1% of non-ESBL MDRO infections were preventable HAMICs. CONCLUSIONS The CDC definition overestimates the preventable proportion of HAMICs with MDROs by more than 50%. Relying only on the CDC definition of HAMICs may lead to inaccurate measurement of the impact of infection control interventions and to inadequate reimbursement under the DRG system. Infect. Control Hosp. Epidemiol. 2016;1-6.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27745555     DOI: 10.1017/ice.2016.226

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

Review 1.  Sex differences in vancomycin-resistant enterococci bloodstream infections-a systematic review and meta-analysis.

Authors:  Carlos L Correa-Martínez; Franziska Schuler; Stefanie Kampmeier
Journal:  Biol Sex Differ       Date:  2021-05-17       Impact factor: 5.027

2.  The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study.

Authors:  Cornelius Remschmidt; Michael Behnke; Axel Kola; Luis A Peña Diaz; Anna M Rohde; Petra Gastmeier; Frank Schwab
Journal:  Antimicrob Resist Infect Control       Date:  2017-09-13       Impact factor: 4.887

3.  Transmission of Vancomycin-Resistant Enterococci in the Hospital Setting: Uncovering the Patient-Environment Interplay.

Authors:  Carlos L Correa-Martinez; Hauke Tönnies; Neele J Froböse; Alexander Mellmann; Stefanie Kampmeier
Journal:  Microorganisms       Date:  2020-01-31

4.  High clonal diversity of ESBL-producing Klebsiella pneumoniae isolates from clinical samples in a non-outbreak situation. A cohort study.

Authors:  Mariona Xercavins; Elena Jiménez; Emma Padilla; Montserrat Riera; Núria Freixas; Lucia Boix-Palop; Josefa Pérez; Esther Calbo
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-03       Impact factor: 4.887

5.  Long-term antimicrobial effectiveness of a silver-impregnated foil on high-touch hospital surfaces in patient rooms.

Authors:  Andreas F Widmer; Sonja Kuster; Marc Dangel; Sammy Jäger; Reno Frei
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-16       Impact factor: 4.887

6.  A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit.

Authors:  Stefanie Kampmeier; Hauke Tönnies; Carlos L Correa-Martinez; Alexander Mellmann; Vera Schwierzeck
Journal:  Antimicrob Resist Infect Control       Date:  2020-09-22       Impact factor: 4.887

7.  Epidemiological and genetic characteristics of vancomycin-resistant Enterococcus faecium isolates in a University Children's Hospital in Germany: 2019 to 2020.

Authors:  Ilona Trautmannsberger; Laura Kolberg; Melanie Meyer-Buehn; Johannes Huebner; Guido Werner; Robert Weber; Valerie Heselich; Sebastian Schroepf; Hans-Georg Muench; Ulrich von Both
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-12       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.